David A. Ford

8.9k total citations · 1 hit paper
169 papers, 6.6k citations indexed

About

David A. Ford is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, David A. Ford has authored 169 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 44 papers in Immunology and 40 papers in Physiology. Recurrent topics in David A. Ford's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (32 papers), Nitric Oxide and Endothelin Effects (22 papers) and Lipid metabolism and biosynthesis (20 papers). David A. Ford is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (32 papers), Nitric Oxide and Endothelin Effects (22 papers) and Lipid metabolism and biosynthesis (20 papers). David A. Ford collaborates with scholars based in United States, Canada and Spain. David A. Ford's co-authors include Carolyn J. Albert, Richard W. Gross, Fong‐Fu Hsu, Stanley L. Hazen, Arun K. Thukkani, Jeffrey E. Saffitz, Bo Wang, Peter Tontonoz, Xin Rong and Ricardo Garcı́a and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

David A. Ford

168 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel mouse model of lipotoxic cardiomyopathy

2001 632 citations David A. Ford et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Ford United States	42	3.4k	1.4k	1.3k	915	867	169	6.6k
Seikoh Horiuchi Japan	57	2.9k 0.8×	1.4k 1.0×	1.6k 1.3×	635 0.7×	1.7k 2.0×	216	10.4k
Oswald Quehenberger United States	50	3.7k 1.1×	2.9k 2.0×	1.4k 1.1×	703 0.8×	1.5k 1.7×	101	8.9k
Eugene A. Podrez United States	34	2.7k 0.8×	2.8k 1.9×	887 0.7×	597 0.7×	1.3k 1.5×	76	6.9k
Renliang Zhang United States	40	2.4k 0.7×	1.7k 1.2×	1.3k 1.0×	330 0.4×	846 1.0×	115	7.0k
David P. Hajjar United States	47	3.9k 1.1×	2.6k 1.8×	1.4k 1.1×	1.0k 1.1×	1.9k 2.2×	111	8.5k
Valerie B. O’Donnell United Kingdom	57	3.8k 1.1×	1.9k 1.3×	2.3k 1.7×	491 0.5×	627 0.7×	145	8.8k
Dolores Pérez‐Sala Spain	45	3.8k 1.1×	670 0.5×	922 0.7×	693 0.8×	754 0.9×	144	6.7k
Anna Dikalova United States	37	2.5k 0.7×	1.5k 1.0×	2.1k 1.6×	357 0.4×	468 0.5×	90	6.5k
Kaikobad Irani United States	53	6.4k 1.9×	2.3k 1.6×	2.7k 2.1×	1.5k 1.7×	790 0.9×	117	11.5k
Gadiparthi N. Rao United States	41	3.0k 0.9×	897 0.6×	622 0.5×	711 0.8×	538 0.6×	130	5.2k

Countries citing papers authored by David A. Ford

Since Specialization

Citations

This map shows the geographic impact of David A. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Ford more than expected).

Fields of papers citing papers by David A. Ford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Ford. The network helps show where David A. Ford may publish in the future.

Co-authorship network of co-authors of David A. Ford

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Ford. A scholar is included among the top collaborators of David A. Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Ford. David A. Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Xiaochao, Thanh Thi Nguyen, Jay McQuillan, et al.. (2025). Insulin regulates lymphatic endothelial integrity via palmitoylation. Journal of Lipid Research. 66(4). 100775–100775. 3 indexed citations

Achanta, Satyanarayana, Michael A. Gentile, Brooke G. Pantazides, et al.. (2024). Recapitulation of human pathophysiology and identification of forensic biomarkers in a translational model of chlorine inhalation injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 326(4). L482–L495. 3 indexed citations

Ford, David A., et al.. (2024). Resolving lipoxin A4: Endogenous mediator or exogenous anti-inflammatory agent?. Journal of Lipid Research. 66(2). 100734–100734.

Pyles, Kelly D., et al.. (2024). Double Cyclization Tandem Mass for Identification and Quantification of Phosphatidylcholines Using Isobaric Six-Plex Capillary nLC-MS/MS. Journal of the American Society for Mass Spectrometry. 35(7). 1403–1412. 1 indexed citations

Tian, Ye, Kritika Mehta, Wei Lu, et al.. (2023). Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis. Hepatology. 79(4). 882–897. 20 indexed citations

Tian, Ye, et al.. (2023). Targeting phospholipid remodeling pathway improves insulin resistance in diabetic mouse models. The FASEB Journal. 37(11). e23251–e23251. 4 indexed citations

PHELPS, KATHLEEN, Christopher S. Eickhoff, Nicola Pozzi, et al.. (2023). Homodimeric Granzyme A Opsonizes Mycobacterium tuberculosis and Inhibits Its Intracellular Growth in Human Monocytes via Toll-Like Receptor 4 and CD14. The Journal of Infectious Diseases. 229(3). 876–887. 4 indexed citations

Tian, Ye, Kritika Mehta, Wei Lu, et al.. (2023). Hepatic Phospholipid Remodeling Modulates Insulin Sensitivity and Systemic Metabolism. Advanced Science. 10(18). e2300416–e2300416. 14 indexed citations

Liu, Xia, Celine L. Hartman, Lingyun Li, et al.. (2021). Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Science Translational Medicine. 13(587). 200 indexed citations

10.

Albert, Carolyn J., et al.. (2021). Identification of novel neutrophil very long chain plasmalogen molecular species and their myeloperoxidase mediated oxidation products in human sepsis. Redox Biology. 48. 102208–102208. 12 indexed citations

11.

Donlin, Maureen J., Eddy C. Hsueh, Theresa Schwartz, et al.. (2020). Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity. Cancer Immunology Research. 9(2). 214–226. 26 indexed citations

12.

McHowat, Jane, et al.. (2020). 2-Chlorofatty Aldehyde Elicits Endothelial Cell Activation. Frontiers in Physiology. 11. 460–460. 11 indexed citations

13.

Sur, Subhayan, Hiroshi Nakanishi, Colin A. Flaveny, et al.. (2019). Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract. Cell Communication and Signaling. 17(1). 131–131. 56 indexed citations

14.

Duerr, Mark A., Elisa N.D. Palladino, Celine L. Hartman, et al.. (2018). Bromofatty aldehyde derived from bromine exposure and myeloperoxidase and eosinophil peroxidase modify GSH and protein. Journal of Lipid Research. 59(4). 696–705. 22 indexed citations

15.

Wang, Helen H., Tiangang Li, Piero Portincasa, et al.. (2017). New insights into the role of Lith genes in the formation of cholesterol-supersaturated bile. Liver Research. 1(1). 42–53. 21 indexed citations

16.

Wang, Bo, Xin Rong, Mark A. Duerr, et al.. (2016). Intestinal Phospholipid Remodeling Is Required for Dietary-Lipid Uptake and Survival on a High-Fat Diet. Cell Metabolism. 23(3). 492–504. 94 indexed citations

17.

Pessac, Bernard, et al.. (2011). Hematopoietic progenitors express embryonic stem cell and germ layer genes. Comptes Rendus Biologies. 334(4). 300–306. 6 indexed citations

18.

Ford, David A.. (2010). Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia. Clinical Lipidology. 5(6). 835–852. 65 indexed citations

19.

Marshall, John, Éric Krump, Thomas F. Lindsay, et al.. (2000). Involvement of Cytosolic Phospholipase A2 and Secretory Phospholipase A2 in Arachidonic Acid Release from Human Neutrophils. The Journal of Immunology. 164(4). 2084–2091. 61 indexed citations

20.

Cramer, E B, Constance A. Cardasis, Gustavo J.S. Pereira, L C Milks, & David A. Ford. (1978). Ultrastructural Localization of Cations in the Rat Pars distalis under Various Experimental Conditions. Neuroendocrinology. 26(2). 72–84. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact